5/4/2022 3:57:33 PM
FDA approves new weight-loss drug
FDA approves potential game-changer drug for weight loss, but it comes with a hefty price tag
FDA approves new weight-loss drug. Wegovy – a semaglutide 2.4 mg injection administered once a week – is specifically for chronic weight management in overweight or obese adults with "at least one weight-related comorbidity," according to pharmaceutical company Novo Nordisk. The drug, which is injected by the patient once a week, is intended to be used in addition to diet and exercise, according to Novo. A four-week supply of Wegovy, which is essentially four injections, will cost consumers around $1,300. Check out the link to read more about this.
4/30/2022 3:19:58 PM
4/30/2022 6:47:25 AM
2/8/2022 10:59:52 PM
1/12/2022 2:47:16 AM
12/31/2021 12:05:30 AM
12/29/2021 9:21:16 PM
10/31/2021 8:03:27 PM
10/18/2021 7:59:00 PM
10/8/2021 6:40:11 PM
10/8/2021 5:05:01 PM
10/8/2021 4:07:27 PM
10/8/2021 1:00:57 PM
10/5/2021 5:20:13 PM
10/5/2021 4:44:04 PM
Report This Post
Please complete the following requested information to flag this post and report abuse, or offensive content. Your report will be reviewed within 24 hours. We will take appropriate action as described in Findit terms of use.
